Patrick Collison Profile picture
Jun 26 1 tweets 5 min read Read on X
This morning, Nature published two papers on bridge editing, the new genome engineering technology from @ArcInstitute: , . I'm quite excited about its potential!

Since the whole thing is pretty arcane, I fed the blog post () to Claude 3.5, and asked it to write an introduction. Below is the rather impressive (unedited) result.

Genome Design: The Bridge to Our Biological Future

I.

Imagine you're trying to edit a document, but instead of a cursor, you have a pair of scissors. You can cut out words you don't like, maybe paste in a few new ones, but precise editing? Forget about it. Now imagine someone hands you a pen. Suddenly, you can write whatever you want, wherever you want. This is the kind of leap we're seeing in the world of genome editing.

For the past few decades, we've been snipping away at genomes with tools like CRISPR, making impressive progress but always constrained by the fundamental nature of our tools: they cut DNA. But what if we could write directly into the genome, inserting whatever we want, wherever we want, without ever making a single cut?

This isn't just a "wouldn't it be nice" daydream anymore. Researchers at the Arc Institute have discovered a new system that does exactly that. They're calling it "bridge recombination," and it might just be the biggest revolution in genetic engineering since CRISPR.

II.

To understand why this is such a big deal, we need to take a quick tour through the history of genetic manipulation.

In the late 1990s, we discovered RNA interference (RNAi). This was our first real taste of programmable biology. We could use short RNA sequences to target and shut down specific genes. It was like having a universal remote control for gene expression. Cool, right?

Then came CRISPR in the early 2010s. Suddenly, we could not just turn genes off, but edit them directly. It was like upgrading from a remote control to a basic text editor. We could cut out bad genes and paste in good ones. But there was always a catch: CRISPR works by cutting DNA, and cells don't always repair those cuts exactly the way we want them to.

Both of these systems were revolutionary, but they shared a common limitation: they were destructive. They worked by breaking things – either the RNA transcripts of genes (in the case of RNAi) or the DNA itself (in the case of CRISPR).

III.

Enter the bridge recombination system.

The researchers at Arc Institute, led by Dr. Patrick Hsu, were poking around in the genomes of bacteria, looking at transposable elements. These are sometimes called "jumping genes" because they can cut themselves out of one part of a genome and paste themselves into another.

They were particularly interested in a group called IS110 elements. These are about as minimalist as you can get while still being functional – just a gene for the enzyme that does the cutting and pasting, plus some mysterious flanking DNA segments.

What they found was surprising. When an IS110 element cuts itself out of a genome, those mysterious flanking segments join up to form an RNA molecule. This RNA folds into two loops, one that binds to the IS110 element itself, and another that binds to the target DNA where the element will insert itself.

This RNA – which they've dubbed "bridge RNA" – is the key to the whole system. It's like a set of instructions, telling the enzyme exactly where to insert the DNA and what DNA to insert.

IV.

Now, you might be thinking, "Okay, that's neat, but how is this different from CRISPR?" The key is in how the insertion happens.

CRISPR works by making a cut in the DNA and then relying on the cell's repair mechanisms to insert the new DNA. It's effective, but it's also a bit like performing surgery with a chainsaw. Sometimes you get exactly what you want, but often you end up with small errors or unwanted insertions or deletions.

The bridge recombination system, on the other hand, doesn't cut the DNA at all. It unzips a small section, inserts the new DNA, and zips it back up again. No broken DNA strands, no relying on error-prone repair mechanisms. It's precise in a way that CRISPR can only dream of.

But the real magic is in the programmability. Remember those two loops in the bridge RNA? They can be programmed to recognize any DNA sequence. This means you can tell the system to insert any piece of DNA into any location in the genome. It's like having a word processor for DNA.

V.

The implications of this are staggering. Here are just a few possibilities:

• Gene Therapy 2.0: Current gene therapy approaches often rely on somewhat random insertion of therapeutic genes. With bridge recombination, we could insert corrective genes exactly where they need to go, without risking disruption of other important genes.
• Synthetic Biology: Want to give an organism a completely new capability? Just design the gene and insert it precisely where you want it.
• Evolutionary Biology: We could insert reporter genes at specific locations across the genome, allowing us to watch evolution happen in real time.
• Agricultural Improvements: We could insert beneficial genes into crops with unprecedented precision, potentially revolutionizing our ability to create drought-resistant or nutrient-enhanced plants.
• Bioengineering: Imagine being able to design and build entire genetic circuits, inserting each component exactly where it needs to be for optimal function.

VI.

In the grand scheme of things, the discovery of bridge recombination feels like a pivotal moment. It's as if we've been trying to write the book of life with a typewriter, and someone just handed us a word processor.

The researchers at Arc Institute have opened a door to a new era of genome design. As with any breakthrough of this magnitude, it's hard to predict exactly where it will lead. But one thing is certain: the future of biology just got a lot more interesting.

As we stand on the brink of this new frontier, I'm reminded of a quote from Arthur C. Clarke: "Any sufficiently advanced technology is indistinguishable from magic." With bridge recombination, we're not just editing the genome anymore. We're writing it. And that, my friends, is pretty close to magic.nature.com/articles/s4158…
nature.com/articles/s4158…
arcinstitute.org/news/blog/brid…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Patrick Collison

Patrick Collison Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @patrickc

Dec 15, 2021
I've long been interested in new ways to organize science and enable curiosity-driven discovery. Today, in partnership with @Stanford, @UCBerkeley, and @UCSF, we're excited to announce Arc Institute, a new undertaking in this vein: arcinstitute.org.
Arc is, fundamentally, a nonprofit that will conduct basic research in a somewhat new way. It’s based on three core ideas. First, betting not on projects, but on people. Arc will fund biomedical investigators to pursue whatever research programs they deem most worthy of study.
This might sound basic, but people tend to be shocked and horrified upon learning how many bureaucratic hurdles the nation's top researchers must contend with. A labyrinth of funding applications typically stands between a good idea and an important result.
Read 11 tweets
Sep 29, 2021
Stripe launched 10 years ago today! Still jump out of the bed as enthusiastically as I did at the outset. (Actually somewhat more so -- wasn't really a morning person back then.)
Ten years in, it feels like we're just *now* starting to properly internalize the possibilities of the space in which we're operating. The bad news about Stripe is that infrastructure takes a long time to build, but the good news is that the benefits can compound for a long time.
Looking forward, the internet + global economies will expand massively over the coming decade, and boost global prosperity to new highs. There are millions of entrepreneurs to enable, businesses to unlock, and allocative efficiencies to improve!
Read 4 tweets
Aug 16, 2021
In December 2020, we noticed a few findings — some of them from Fast Grants-funded scientists — that led us to be optimistic that fluvoxamine might be an effective Covid-19 treatment.
We sent a call for proposals to all of the Fast Grants recipients. Tyler also posted a version of it on MR: marginalrevolution.com/marginalrevolu….
Based on the responses, we funded two clinical trials for fluvoxamine. One of those trials failed to recruit enough participants. Another did and the results are summarized here: blogs.jwatch.org/hiv-id-observa….
Read 6 tweets
Dec 15, 2020
Someone I know has had some quite useful COVID-related posts removed from Medium, LinkedIn, and Nextdoor—they've been deemed "COVID misinformation". (It's not what the WHO endorses!)
I think his posts overstate the case for the treatment he’s arguing for. They aren’t without justification, however. He has some considerable scientific evidence on his side (including a small RCT).
This year, we’ve come to better appreciate the fallibility and shortcomings of numerous well-established institutions (“masks don’t work”)… while simultaneously entrenching more heavily mechanisms that assume their correctness (“removing COVID misinformation”).
Read 7 tweets
Mar 14, 2020
Hard to find good stuff online but WWII Committee on Medical Research probably has useful lessons. In very short order, figured out how to scale penicillin production, found better malaria antivirals (including chloroquine!), huge improvements in blood transfusions/replacements…
These programs were *fast*. (Just over one year from formation of board to coordinate work on malaria to getting the first therapeutics shipped.)
There's lots of precedent for rapid, successful, directed medical research led/coordinated by US Government.
Read 5 tweets
Apr 30, 2018
You can now incorporate an LLC with @Stripe Atlas: stripe.com/blog/atlas-llc
This has been the #1 feature request since Atlas launched.

More from TechCrunch: techcrunch.com/2018/04/30/str…
It may be worth touching on why we're building Atlas. Partly, it's to make access to infrastructure for entrepreneurship as broadly and cheaply available as possible. Talent is uniformly distributed... but opportunity is not. We want to help correct that.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(